Intended for healthcare professionals

CCBYNC Open access
Research

Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6333 (Published 31 October 2011) Cite this as: BMJ 2011;343:d6333